40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
5.73%
Revenue growth below 50% of CRK's 48.73%. Michael Burry would check for competitive disadvantage risks.
1.43%
Cost growth less than half of CRK's 9.54%. David Dodd would verify if cost advantage is structural.
14.09%
Gross profit growth below 50% of CRK's 96.80%. Michael Burry would check for structural issues.
7.90%
Margin expansion below 50% of CRK's 32.32%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
-6.01%
G&A reduction while CRK shows 2.29% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-14.29%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-3.13%
Operating expenses reduction while CRK shows 2.29% growth. Joel Greenblatt would examine advantage.
-0.28%
Total costs reduction while CRK shows 9.25% growth. Joel Greenblatt would examine advantage.
-22.22%
Both companies reducing interest expense. Martin Whitman would check industry trends.
-4.73%
D&A reduction while CRK shows 6.01% growth. Joel Greenblatt would examine efficiency.
45.97%
EBITDA growth while CRK declines. John Neff would investigate advantages.
31.64%
EBITDA margin growth exceeding 1.5x CRK's 6.36%. David Dodd would verify competitive advantages.
104.96%
Similar operating income growth to CRK's 101.88%. Walter Schloss would investigate industry trends.
104.69%
Operating margin growth exceeding 1.5x CRK's 35.74%. David Dodd would verify competitive advantages.
8.33%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
65.37%
Pre-tax income growth while CRK declines. John Neff would investigate advantages.
67.24%
Pre-tax margin growth exceeding 1.5x CRK's 28.30%. David Dodd would verify competitive advantages.
-99.06%
Tax expense reduction while CRK shows 135.17% growth. Joel Greenblatt would examine advantage.
64.88%
Net income growth while CRK declines. John Neff would investigate advantages.
66.78%
Net margin growth while CRK declines. John Neff would investigate advantages.
64.56%
EPS growth while CRK declines. John Neff would investigate advantages.
64.56%
Diluted EPS growth while CRK declines. John Neff would investigate advantages.
-0.91%
Share count reduction while CRK shows 0.73% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.